Search

A recent study conducted by Rutgers University in New Jersey examined the relationship between state-level medical cannabis laws (MCL) and non-medical prescription opioid (NMPO) use among adults in the United States. The study found that MCL was associated with an increase in occasional NMPO use, but a decrease in regular and frequent NMPO use. These changes were primarily observed in adults with cannabis use disorder. The research suggests that while MCL may reduce opioid-related harms, it is important to consider the tradeoffs of cannabis legalization. [Extracted from the article]

A recent study conducted by Rutgers University in New Jersey examined the impact of state-level medical cannabis laws (MCL) on individual-level opioid outcomes. The study found that the association between MCL and lower frequency of non-medical prescription opioid (NMPO) use was driven by individuals with cannabis use disorder. This highlights the importance of considering the tradeoffs of cannabis legalization as an intervention to reduce opioid-related harms. The research has been peer-reviewed and provides valuable insights into the relationship between medical cannabis laws and opioid use. [Extracted from the article]

(Bloomberg) -- New Jersey recreational marijuana sales will begin on April 21, Governor Phil Murphy said in a tweet. New Jersey is taking a stepped approach to retail pot sales, with the first allowed at medical dispensaries, which have operated in the state since 2012. [Extracted from the article]

The article analyzes the medical use of marijuana, as medicinal marijuana is now legal in New Jersey. It is stated that, although medicinal marijuana is now legal in the state, the fact that only few doctors have any formal training in the field of medicinal marijuana has resulted in widespread uncertainty about how to prescribe, administer, and monitor the drug.

Last week, Gov. Phil Murphy announced that New Jersey would remove prior authorization for Medicaid for medication‐assisted treatment (MAT) and would approve opioid use disorder as an eligible indication for medical marijuana. The moves, among several announced Jan. 23 in the state's efforts to combat the opioid epidemic, would increase access to treatment. Last year, more than 3,000 individuals in the state died from overdoses. "The opioid epidemic continues to devastate families and communities across our state," said Gov. Murphy. "As we combat this crisis, it is critical that we use data‐driven, evidence‐based strategies to support individuals suffering from addiction and help them get on the path to recovery." [ABSTRACT FROM AUTHOR]

The article reports that legalization of recreational marijuana and expansion of medical cannabis program in New Jersey with prompt opportunities number of law firms and includes Patrick Harrity, an associate at McCarter & English LLP. INSET: It takes ALL KINDS..

The article discusses the rules related to home delivery medical marijuana to patients in New Jersey and includes comments by Jeff Brown, assistant commissioner for medicinal marijuana at the New Jersey Department of Health' (DOH)

The article reflects on the importance of perception in cannabis businesses as per the view of panel members of NJBIZ's Business of Cannabis event. Comments by panelists Jim Minninger, corporate security specialist at Viridis Se­curity, Bill Ca­ruso, head of the cannabis practice at law firm Archer & Greiner PC and Rosie Naumovski, vice president of Treatment Solutions of New Jersey Inc., are included.

The article discusses the challenges for marijuana legalization in New Jersey. It refers to a confluence of multiple issues as the problem with passing a cannabis bill in the state including taxation, regulatory control and expungement. It discusses the exorbitant cost associated with enforcement of a failed policy and consequences of excessive and unfair enforcement.

New Jersey's plan to expand the medical marijuana business in the state has drawn 146 applications from would-be providers, more than 24 times the number of new dispensaries expected to open. Murphy expanded the list of medical conditions eligible for marijuana treatment, leading to the higher enrollment, and he increased New Jersey's target for dispensaries to as many as 12 from six. [Extracted from the article]

The article informs that New Jersey in partnership with Nuka Enterprises, is bringing chocolate marijuana into the state, along with statement of Peter Barsoom, chief executive officer (CEO) of Nuka on providing medical marijuana for patients with pain or anxiety.

Despite the effectiveness of the treatment, M&K refused to reimburse the cost of his medical marijuana under the company's workers compensation insurance because, while legal under state law, marijuana is still federally illegal. Notably, even though medical marijuana programs exist in the majority of states, M&K could not identify a single case where an insurance company or employer was prosecuted for reimbursing expenses for authorized medical marijuana treatment. [Extracted from the article]

The article reports on the hopes of medical marijuana supporters in New Jersey that the first dispensaries will open in 2012. Former Governor Jon S. Corzine legalized the medical marijuana bill in January 2010 while his successor Chris Christie selected six nonprofit organizations to open dispensaries. Christie also hired former state police Lieutenant John O'Brien to oversee the program. But suspicion arose after Christie suspended its implementation for a month.

The article presents U.S. news briefs related to drug abuse. The New Jersey Legislature has legalized the use of drug marijuana for patients suffering with chronic ailments like cancer and Lou Gehrig's disease. Senator David Thomas has proposed a bill in South Carolina that would necessitate testing for illegal drugs in people enjoying unemployment benefits. The Statewide Peer Assistance Program enables nurses with addiction problems to surrender the licence until their treatment is complete.

The article offers news briefs in the U.S. in 2012. The first medical marijuana dispensary will be opened in New Jersey. The 70-minute documentary film "God Save My Shoes" include interviews with designers Manolo Blahnik and Christian Louboutin and aficionada Fergie of the Black Eyed Peas. Caprice Holdings Ltd. has secured its new location in Manhattan, New York.

Several letters to the editor are presented in response to articles in previous issues including "Jersey's Jammin'," by Tammy La Gorce in the November 2011 issue, "Hot and Cold: The Year in Review," in the December 2011 issue, and "Weeding out the Pain," in the November 2011 issue.

This section offers news briefs on the New Jersey business community including legislation which aims to clarify the employment of independent truckers, the rejection of nonprofit organizations who want to produce medical marijuana by Governor Chris Christie, and the poor showing of Rutgers University in a ranking of universities based on the number of collegiate merchandise sold.

The author presents opinions on various issues surrounding New Jersey including the financing of LS Power plant construction through the LS Power bill, uncertainty in the evaluation of medical marijuana award winners by the New Jersey Department of Health and Senior Services, and expiration of the two-year extension for counties to send wastewater management strategies.